CollaCote, CollaTape, CollaPlug, Absorbable Collagen Wound Dressings for Dental Surgery
Integra Lifesciences Corp. · Decision date Sep 18, 2026
What did the FDA decide?
The supplied record identifies PMA supplement P840062/S099 for Integra Lifesciences Corp. under product code LPG, in the Dental specialty, with the device category listed as a surgical dressing material. It is a 30-Day Notice with the reason given as a process change affecting manufacturer, sterilizer, packager or supplier, and its decision is recorded as OK30 with a date of 2026-09-18.
The source statement describes the reported change as installation and qualification of a new Water for Injection pretreatment, generation, storage, and distribution system. The record does not state where the system sits in the manufacturing flow, which dressing products it affects, or what qualification criteria were applied, so those details are absent rather than implied. The identifier links this filing to the original PMA P840062, but a supplement is not a new approval of the whole system, and the reported purpose does not by itself establish safety or clinical effectiveness.
FDA approval order statement
installation and qualification of a new Water for Injection (WFI) pretreatment, generation, storage, and distribution system
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Dental
- Decision date
- Sep 18, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P840062/S099
- Regulatory pathway
- PMA supplement
- Applicant
- Integra Lifesciences Corp.
- Product code
- LPG
- Decision code
- OK30
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: MATERIAL, DRESSING, SURGICAL, POLYLACTIC ACID.
- Applicant
- Integra Lifesciences Corp.
- Product code
- LPG
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P840062. Subsequent supplements may change the device or its indications.
FDA decision timeline
P840062 · Original PMA
COLLACOTE(TM)
P840062/S099 received
Application receipt date recorded by FDA.
P840062/S099 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P840062. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P840062
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
COLLACOTE(TM)P840062 | Integra Lifesciences Corp. | PMA approval | Nov 8, 1985 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Integra Lifesciences Corp.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 311 Enterprise Dr., Planisboro, NJ, 08536
Sources and methodology
- Original FDA record: P840062/S099
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records